Sign Out
Pregnancy and Lactation: US FDA category: B.
There are no adequate and well-controlled studies in pregnant women; therefore, the safety of MAGLITIN in pregnant women is not known. MAGLITIN, like other oral antihyperglycemic agents, is not recommended for use in pregnancy. It is not known whether the drug is distributed into human milk. Therefore, MAGLITIN should not be used by women who are nursing.
Continue with Google